Skip to main content
. Author manuscript; available in PMC: 2018 Aug 22.
Published in final edited form as: J Alzheimers Dis. 2018;62(4):1815–1826. doi: 10.3233/JAD-170954

TABLE 1.

Characteristics of African-Americans and Caucasians in the Emory cohort of 37 subjects with clinically diagnosed and pathologically confirmed AD.

Variable African-Americans (n=18) Caucasians (n=19) p value
Age at death (yrs)+ 73.8 ± 12.4 75.1 ± 10.4 0.75
Duration (yrs)+^ 9.4 ± 4.2 10.8 ± 4.1 0.34
PMI (hrs)+ 17.6 ± 13.0 12.2 ± 6.8 0.12
Gender n (%) 0.64
 Male 6 (33%) 5 (26%)
 Female 12 (67%) 14 (74%)
APOE genotype n (%)^^
ε4/4 6 (33%) 3 (17%)
ε3/4 8 (44%) 10 (56%)
ε3/3 4 (22%) 4 (22%)
ε2/4 0 1 (6%)
APOEε4-positive n (%)^^ 0.61
 Yes 14 (78%) 14 (78%)
 No 4 (22%) 4 (22%)
Hypertension n (%) 14/16 (88%) 2/15 (13%) <0.001
Education (yrs)§ 14.6 ± 3.3 14.9 ± 2.4 0.77

All percentages are rounded to the nearest whole number

APOE: apolipoprotein E

PMI: postmortem interval

+

Mean ± standard deviation

^

Time from diagnosis to death; Data not available for 2 Caucasians

^^

Data not available for 1 Caucasian

Data not available for 2 African-Americans and 4 Caucasians

§

Data not available for 6 African-Americans and 6 Caucasians

Statistically non-significant